Skip to main content
Prakash Peddi, MD, Oncology, Shreveport, LA

PrakashPeddiMDMS

Oncology Shreveport, LA

Breast Cancer, Hematologic Oncology

Oncology/ Hematology

Dr. Peddi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Peddi's full profile

Already have an account?

  • Office

    2600 Kings Highway
    Suite 340
    Shreveport, LA 71103
    Phone+1 318-212-8620
    Fax+1 318-212-8687

Education & Training

  • Louisiana State University School of Medicine
    Louisiana State University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Louisiana State University School of Medicine
    Louisiana State University School of MedicineResidency, Internal Medicine, 2007 - 2010
  • East Carolina University
    East Carolina UniversityM.S., Molecular Biology and Biotechnology, 2004 - 2007
  • Brody School of Medicine at East Carolina University
    Brody School of Medicine at East Carolina UniversityClass of 2004, MS

Certifications & Licensure

  • LA State Medical License
    LA State Medical License 2010 - 2024

Awards, Honors, & Recognition

  • Healer Award 2016 Healer Award, 2016
  • Healer Award Louisiana State University, 2016

Publications & Presentations

PubMed

Journal Articles

  • Cisplatin, Cetuximab, and Radiation in Locally Advanced Head and Neck Squamous Cell Cancer: A Retrospective Review  
    Prakash Peddi, Runhua Shi, Binu Nair, Fred Ampil, Glenn M. Mills and Syed H. Jafri, Clinical Medicine Insights: Oncology 2015:9 1-7, 1/4/2015
  • Lactic Acidosis and Atrial Tachycardia: An Unusual Presentations of Disseminated Burkitt's lymphoma  
    El-Osta H, Abdulbaki A, Peddi P, Takalkar A, Cotelingam J, Veillon D, Vargas A, Akkus N and Hildebrandt C.G., Journal of Cancer Therapy, 1/1/2012
  • Utility of Routine Pre-Treatment Evaluation of Left Ventricular Ejection Fraction in Breast Cancer Patients Receiving Anthracyclines  
    Peddi P, Master RS, Dwary DD, Ravipati PH, Patel A, Katikaneni KP, Shi R, Burton VG, Chu DQ, The Breast Journal

Abstracts/Posters

  • Eltrombopag Improves Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
    Samip M, Peddi P, Koshy N, Mills G, Mansour R, BMT Tandem Meeting, Orlando, FL, 1/1/2017
  • Eltrombopag Improves Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
    Master S, Koshy N, Peddi P, BMT Tandem Meetings, Orlando, FL, 1/1/2017
  • Pre-treatment evaluation of LVEF for Breast Cancer Patients Receiving Anthracyclines. Is it Necessary
    Peddi P, Master S, Pasam A, Ravipati H, Patel A, Dwary A, Shi R, Burton G, J Clin Oncol, 1/1/2016
  • Join now to see all

Lectures

  • Breast Cancer Review for Internal Medicine residents 
    1/1/2019
  • Management of Metastatic Soft Tissue Sarcoma 
    1/1/2019
  • Soft Tissue Sarcoma- Basics and Molecular Biology 
    1/1/2019
  • Join now to see all

Professional Memberships